.Merck defeats earnings requirements, raises sales overview on solid demand for top drugs like Keytruda CNBCMerck & Co. (MRK United States) Defeats Income Estimates as Keytruda Purchases Increase BloombergMerck Stock: Pharma Giant Posts Powerful End Results, Yet Expectation Falls Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats income as well as purchases assumptions amid Keytruda strength, yet provides mixed full-year outlook MarketWatch.